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PURPOSE: Infection is the leading complication of long-term central venous catheters, and its incidence may vary
according to catheter type. The objective of this study was to compare the frequency and probability of infection between
two types of long-term intravenous devices.
METHODS: Retrospective study in 96 onco-hematology patients with partially implanted catheters (n = 55) or
completely implanted ones (n = 42). Demographic data and catheter care were similar in both groups. Infection incidence
and infection-free survival were used for the comparison of the two devices.
RESULTS: In a median follow-up time of 210 days, the catheter-related infection incidence was 0.2102/100 catheter-
days for the partially implanted devices and 0.0045/100 catheter-days for the completely implanted devices; the infection
incidence rate was 46.7 (CI 95% = 6.2 to 348.8). The 1-year first infection-free survival ratio was 45% versus 97%, and the
1-year removal due to infection-free survival ratio was 42% versus 97% for partially and totally implanted catheters,
respectively (P <.001 for both comparisons).
CONCLUSION: In the present study, the infection risk was lower in completely implanted devices than in partially
implanted ones.
KEY WORDS: Infection. Completely-inserted catheter. Partially-inserted catheter. Incidence. Lymphoma.
Since their development in the
early 1970s, long-term venous cath-
eters have been increasingly used on
cancer patients, aiming at improving
their quality of life and treatment. De-
spite having facilitated the care for
such patients, these devices are not ex-
empted from complications, and infec-
tions rank as the most common com-
plications.1 Various reports have dem-
onstrated that partially-implanted
catheters are associated with higher in-
fection risks compared to completely-
implanted catheters,2,3,4,5 although
such correlation has not been con-
firmed in some selected retrospec-
tive6,7 and randomized8,9 studies. The
majority of the published series
analyzed patients with various types of
neoplasias, and there is little data on
the risk of infections as they relate spe-
cifically to catheters on patients with
hematological malignancies,10,11,12 in
addition to the fact that few reports
have been issued by Brazilian
centers.13,14
A retrospective study was thus car-
ried out in a population of ambulatory
patients with lymphomas, aiming at as-
sessing the incidence of infectious
complications related to catheters, and
to determine whether the type of cath-
eter was in any way related to the risk
of infection, as well as to the risk of
infection-related removal of the de-
vice.
3215.p65 15/10/2004, 15:36291
292
REV. HOSP. CLÍN. FAC. MED. S. PAULO 59(5):291-295, 2004Comparison of catheter-related infection risk
Pracchia LF et al.
METHODS
All patients with lymphomas stage
I to IV and implanted long-term cath-
eters admitted to the chemotherapy
unit of Pró-Sangue Foundation be-
tween January 1994 and January 2001
were included in the study. Patients
with non-Hodgkin’s lymphoma (n =
43) were treated with the CHOP pro-
tocol (cyclophosphamide 750 mg/m2
on day 1 IV, adriamycin 50 mg/m2 on
day 1 IV, vincristine 2.0 mg on day 1
IV, and prednisone 60 mg/m2 on day 1
to 5 PO), or similar15; patients with
Hodgkin’s lymphoma (n = 54) were
evenly treated with the ABVD proto-
col (adriamycin 25 mg/m2, bleomycin
10 mg/m2, vinblastine 6 mg/m2, and
dacarbazine 375 mg/m2, all adminis-
tered on day 1 and 15 of a 28-day cy-
cle), or similar.16 In case of
refractoriness or relapse, all patients
were treated with ifosfamide-based17
second-line protocols. All catheters
had been implanted in operating
theaters by skilled surgeons in strict
accordance with aseptic techniques.
The brands and models of all devices
varied throughout the length of the
study, depending on the purchase pro-
cedures set forth by the institution. All
patients were taught in-home catheter
cleansing procedures: for those with
partially-implanted catheters (PIC),
daily cleansing of exit site and cath-
eter extension with degerming
chlorhexidine 4% during aspersion
bath followed by the application of al-
coholic chlorhexidine 0.5% and dress-
ing with sterile dry gauze and tape. All
patients bearing completely-im-
planted catheters (CIC) performed
daily dressings, as explained above,
until suture removal.
The catheters were used for chemo-
therapy administration, transfusion of
hemocomponents, and collection of
specimen for tests, as required. During
the length of the study, catheters were
manipulated solely by trained nurses,
according to standardized aseptic tech-
niques. All ambulatory dressings were
performed with alcoholic chlorhexi-
dine 0.5%, sterile dry gauze, and tape.
The permeability of the catheters was
maintained by means of the weekly
application of 2.5 mL of heparin solu-
tion at 100 U/mL to all lumens of PICs
and 4.0 mL once a month to the CIC.
When bacteremia was suspected, pe-
ripheral and via-catheter hemocultures
were collected whenever there was
blood reflux in the devices. The deci-
sion for the removal of devices was
made by the attending physician, the
proximal portion (tip) of all removed
being sent to quantitative culture.
All patients’ charts and microbio-
logical exams were reviewed for iden-
tification of infection episodes. Cath-
eter-related infections were defined as
follows:
Bacteremia - presence of signs and
symptoms of bacteremia (fever, chills,
shivers, whether or not with hypoxia
or hypotension) that began within 6
hours of catheter manipulation, in the
absence of any other evident infectious
cause, associated with positive periph-
eral hemoculture and positive hemo-
culture via catheter, or positive periph-
eral hemoculture and positive quanti-
tative culture of catheter’s tip, with
more than 15 CFUs (colony forming
units) in which the same microbiologi-
cal agents were isolated, having equal
sensitivity patterns to the anti-
microbials.
Localized infection - inflamma-
tion, edema, erythema, and pain in the
subcutaneous tunnel.
Infection rates were calculated
based on their incidence per 100 cath-
eter-days, and the comparison of the
rates was performed by comparing the
incidence of PIC/CIC infection, with
a 95% confidence interval. The rate of
infection-related removal was deter-
mined from the following ratio:
number of catheters removed due to
infection / total number of catheters.
The removal-due-to-infection survival
time (number of days from the date of
the first ambulatory evaluation to the
removal of catheter due to infection),
and the first-catheter-infection sur-
vival time (number of days from the
date of the first ambulatory evaluation
to the onset of the first infection) were
also calculated using the Kaplan-
Meier18 method. All patients without
infection or removal due to infection
in the whole follow-up period were
censored and the date of their last
evaluation was used in the survival
analysis. The comparison of survival
curves and infection probability in 1
year were performed with the log-rank
test. To compare age medians, the non-
parametric Mann-Whitney test was
used; to compare percentages, the
Fisher exact test was used. All tests
were 2-tailed, with a 5% significance
level.
RESULTS
Out of the 96 patients analyzed, 54
(56%) had partially-implanted cath-
eters (PIC), and 42 (44%) had com-
pletely implanted catheters (CIC).
Both groups had comparable demo-
graphic characteristics, as demon-
strated in Table 1.
One patient had more than 1 im-
planted catheter, totaling 97 catheters
for analysis. In a median follow-up pe-
riod of 210 days (range: 3 to 1,436
days), the incidence of infections in
patients with PICs was 0.2102/100
catheter-days, and 0.0045/100 cath-
eter-days in patients with CICs. The
infection-incidence rate among pa-
tients with PICs and patients with
CICs was 46.7 (CI 95% = 6.2 to 348.8).
The median first infection-free sur-
vival time was 298 days for patients
with PICs, and was not reached for pa-
tients with CICs (P <.001). The ratio
of first infection-free survival in 1 year
was 45% for patients with PICs and
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97% for patients with CICs (P <.001).
The first infection-free survival curves
for both groups are represented in Fi-
gure 1.
The median removal due to infec-
tion-free survival time was 298 days
for patients with PICs, and was not
reached for patients with CICs (P
<.001). The ratio of removal due to in-
fection-free survival time in 1 year was
42% for patients with PICs, and 97%
for patients with CICs (P <.001 - Fi-
gure 2).
The rate of infection-related device
removal was higher among patients
with PICs. Out of the 55 catheters in
patients with PICs, 20 (36.4%) were re-
moved due to infection; while out of
the 42 catheters on patients with CICs,
only 1 (2.4%) was removed due to in-
fection (P <.001). The comparison of
infection-related device removals for
both groups is shown on Table 2.
DISCUSSION
In the present study, partially-im-
planted catheters were associated with
a higher frequency of infection in a
population of patients with similar di-
agnoses and undergoing similar treat-
ments. The incidence of infection in
this type of device was 0.2102/100
catheter-days, while, for completely-
implanted catheters, it was 0.0045/100
catheter-days. This tendency to a lower
infection rate in completely-implanted
catheters has also been described in
international series, in which the infec-
tion rate varied from 0.1 to 1.9/100
catheter-days in partially-implanted
devices, and from 0 to 0.18/100 cath-
eter-days in completely-implanted de-
vices.2-9 Two issues stand out in the
evaluation of these results. First, the
infection incidence rates cannot be di-
rectly compared across the different
studies due to the great variability in
the definition of catheter-related infec-
tion in each of them. Second, the defi-
Table 1 – Demographic data.
 PIC Patients CIC Patients
n = 54 n = 42  
Age – years
median (range) 37 (14 – 67) 30 (13 – 67) P = .431
Male Sex
n (%) 35 (63.6) 22 (52.4) P = .322
PIC – partially implanted catheter, CIC – totally implanted catheter, 1 - Mann-Whitney test, 2
– Fisher exact test.
Figure 1 - Comparison of first infection-free survival curves. Survival curve indicates percentage
of catheters that remain infection free over time. PIC – partially implanted catheter, CIC –
totally implanted catheter.
Figure 2 - Comparison of removal due to infection-free survival curves. Survival curve
indicates percentage of catheters that were not removed due to infection over time. PIC –
partially implanted catheter, CIC – totally implanted catheter.
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nition of catheter-related bacteremia
used in the present study was very re-
strictive in an attempt to identify with
maximum certainty only those infec-
tions that were related to catheters.
This restrictive criterion may have
contributed to an underestimation of
the infection incidence, yet it does not
render invalid the comparison of rates
between the two different devices.
We also observed that the first in-
fection-free survival time was remark-
ably different between types of cath-
eters. PICs presented higher risk for in-
fection, which was continuous during
the whole period of use, while CICs
presented lower risk for infection, and
none was observed after the 200th day
of use. It is known that the colonization
of the catheter hub is one of the main
sources for endoluminal contamination
and infection in long-term devices.1
Therefore, it is possible that the con-
tinuous exposure of non-implanted
parts of the PIC to the environment may
favor their colonization, thus becoming
responsible for the higher risk for infec-
tion of such devices.
The duration and intensity of neu-
tropenia episodes, also known as other
important risk factors for catheter-re-
lated infection,6 were not analyzed in
this study. However, since all patients
in this series had the same type of neo-
plasia, and all underwent similar treat-
ments, it is unlikely that there are
great differences in the frequency of
neutropenia across patients with either
type of catheter. Thus, it is unlikely
that differences in duration and inten-
sity of episodes of neutropenia ac-
counted for the higher incidence of in-
fection observed in patients with PICs.
The possible causes for the higher
infection risk in partially-implanted
catheters are not fully known. Other
risk factors for catheter infection, such
as hub colonization rates19, type of
cancer20, administration of parenteral
nutrition21, frequency of device use22,
model of catheter hub,23,24 in addition
to the factors related to the in-home
methods deployed by patients to care
for catheters, have not been well stud-
ied, but they may change the infection
incidence with catheters. Certainly,
the interaction of all these factors,
some of which are difficult to control
even in prospective clinical studies,
may explain the diverging results
found by other authors.6-9
We conclude that in our series of
onco-hematology patients, the par-
tially-implanted catheters were related
to a higher incidence of infection;
higher infection probability within 1
year of catheter implantation, and a
lower permanence length due to a
higher probability of infection-related
device removal. It is important to re-
mark that, given the retrospective de-
sign of the present study and the ex-
istence of multiple risk factors for cath-
eter infection, unrecognized biases
may have influenced the results. It is
of fundamental importance that par-
ticular aspects of different countries,
hospitals, and patient populations be
taken into account for the choice of
the catheter to be used.
Table 2 – Rate of infection-related catheter removal.
 PIC Patients CIC Patients
n = 551 n = 42  
Removed due infection
n (%) 20 (36.4) 1 (2.4)
P <.0012
Not removed due infection
n (%) 35 (63.6) 41 (97.6)
PIC – partially implanted catheter, CIC – totally implanted catheter, 1 – one patient had 2
implanted catheters, 2 – Fisher exact test.
RESUMO
PRACCHIA LF e col. Comparação do
risco de infecção relacionada a
cateteres entre dois tipos de dispo-
sitivos de longa permanência em
pacientes onco-hematológicos.
Rev. Hosp. Clín. Fac. Med. S.
Paulo 59(5):291-295, 2004.
OBJETIVO: Infecção é a princi-
pal complicação relacionada ao uso de
cateteres venosos de longa permanên-
cia em pacientes oncológicos e sua in-
cidência pode variar a depender do
tipo de cateter utilizado. O objetivo
deste estudo foi comparar a freqüência
e risco de infecção entre dois tipos de
dispositivos de longa permanência.
MÉTODOS: Estudo retrospectivo
com 96 pacientes onco-hematológicos
portadores de cateteres parcialmente
implantáveis (n=55) ou totalmente
implantáveis (n=42). Dados demo-
gráficos e cuidados com o dispositivo
foram similares entre os dois grupos.
A comparação entre os dispositivos foi
realizada através da avaliação da inci-
dência de infecção e da sobrevida li-
vre de infecção.
RESULTADOS: Em uma mediana
de acompanhamento de 210 dias, a in-
cidência de infecção relacionada ao
cateter foi de 0,2102/100 cateter-dias
para os dispositivos parcialmente
implantáveis e de 0,0045/100 cateter-
dias para os totalmente implantáveis,
com uma razão de incidência de 46,7
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(IC 95% = 6,2 a 348,8). A taxa de
sobrevida livre de primeira infecção
em um ano foi de 45% versus 97% e a
taxa de sobrevida livre de retirada por
infecção foi de 42% versus 97%, res-
pectivamente para cateter parcialmen-
te ou totalmente implantável (p<0,001
para ambas comparações). Conclusão:
No presente estudo, o risco de infec-
ção foi menor nos dispositivos total-
mente implantáveis do que nos parci-
almente implantáveis.
UNITERMOS: Infecção. Incidên-
cia. Cateter totalmente implantável.
Cateter parcialmente implantável.
Linfoma.
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